Pharma News: Vivus, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA)’s Settled Stock & Amgen, Inc. (AMGN)’s Clinical Trial

Editor’s Note: Related tickers: VIVUS, Inc. (NASDAQ:VVUS), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Amgen, Inc. (NASDAQ:AMGN)

Pfizer Elected to Continue Development of Tamper-resistant Painkiller Remoxy – VIVUS, ARNA, ARIA, MNKD, MRK, PFE (FiscalInsider)
Investors in Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) saw new options become available this week, for the April 2014 expiration. …VIVUS, Inc. (NASDAQ:VVUS) is on the decline this week, earning a D (“sell”) after receiving a C (“hold”) last week. For Portfolio Grader’s specific subcategory of Equity, VVUS also gets an F. The stock price has dropped 6.1% over the past month, worse than the 1.3% decrease the NASDAQ has seen over the same period of time VIVUS, Inc. (NASDAQ:VVUS) shares plunged -0.81% to $12.23 in last trading session. Stock traded in range of $12.00 – $12.41.

VIVUS, Inc. (NASDAQ:VVUS)

Onyx trials cloud Amgen deal (TheDeal)
A Bloomberg article that ran Aug. 14 cited anonymous sources saying that Amgen, Inc. (NASDAQ:AMGN)‘s $10 billion, $120 per share acquisition of Onyx Pharmaceuticals Inc. was hanging on whether Amgen could see results of a clinical trial for Onyx’s Kyprolis. However, the reference to the study results was ambiguous and left parties tracking the deal trying to figure out which trial the sources were alluding to and whether access to the data could truly be a deal-breaker.

Biotech Stocks in News, VIVUS Inc, Arena Pharmaceuticals Inc, Ariad Pharmaceuticals Inc, MannKind Corporation, Affymax, Pfizer Inc (FiscalInsider)
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) is a controversial stock among biotech investors. The bulls believe that increasing rates of global obesity will inevitably trigger more sales of its new weight loss drug, Belviq, which was approved by the FDA last June. However, the bears believe that lingering safety concerns regarding Belviq and the company’s insistence on combining the treatment with other medications could cause problems down the road. Arena shares plunged -0.44% to $6.80 in last trading session. Stock traded in range of $6.75 – $6.91.

Amgen Rating Reiterated by Goldman Sachs Group Inc. (AMGN) (WatchlistNews)
Goldman Sachs Group Inc. reiterated their buy rating on shares of Amgen, Inc. (NASDAQ:AMGN) in a research report released on Friday morning, ARN reports. A number of other firms have also recently commented on AMGN. Analysts at RBC Capital raised their price target on shares of Amgen, Inc. (NASDAQ:AMGN) from $120.00 to $125.00 in a research note to investors on Thursday, August 1st. They now have an outperform rating on the stock.

Investor’s Alert -Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Plug Power Inc (NASDAQ:PLUG), Targacept, Inc. (NASDAQ:TRGT), Inc. (NASDAQ:GTXI) (Techsonian)
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. …Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) managed to keep its gain at 1.44% on below normal -average volume of 2.71M shares. The stock settled at $7.06 after floating in a range of $6.95 to $7.13. Significantly, its latest price is at a discount of -14.25% to its 200-day moving average price.

Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 10 Most Expensive iPhone Apps

The 9 Most Expensive Designer Shoes in the World

The 10 Most Expensive Cigarette Brands

The 10 Most Expensive Law Schools in the US

The 10 Best Wall Street Movies

The 10 Most Expensive Golf Clubs Ever Sold

The 10 Most Expensive Golf Memberships

The 10 Best Disney Characters Ever Created

The 8 Best Foods for Gaining Weight

The 10 Most Expensive Colleges in the World

The 7 Most Memorable Ad Campaigns of All Time

The 7 Most Expensive High Schools in the World

The 10 Electric Vehicles with the Longest Range

The 10 Cities with the Worst Drivers in the World

The 10 Most Expensive Dresses Ever Created

10 Islands to Visit Before You Die

10 Famous Celebrities Who Needed Rehab

The 15 Countries with the Largest Oil Reserves

The 10 Most Overused Excuses in the World

The 5 Best iOS Apps You Can’t Get on Android

5 Companies Damaged By Social Media Blunders

The 10 Most Legendary Blues Songs

The 10 Most Lawless Places in the World

4 Reasons China is a Threat to the US

The 17 Most Sugary Drinks in the World

The 10 Most Ruthless Rulers in History

The 10 Greatest Generals in History

Top 8 Travel Destinations for 2015

The 10 Safest Dog Breeds for Children

The 10 Most Stolen Vehicles in the US

The 7 Most Expensive Celebrity Weddings

The 10 Best LoL Teams in the World

Top 10 Worst Marketing Campaigns Ever Produced

Top 5 Diets that Help You Lose Weight

The 10 Best Ways to Stay Awake

7 Artists That Switched Musical Genres

The 10 Most Expensive Cities to Live in New Jersey

The 10 Best High Schools in New York

The 10 Countries With the Least Gender Inequality

The 6 Biggest Musician-Manager Feuds

The 10 Countries with the Cheapest Gas Prices

The 7 Most Theatrical Bands of All Time

The 8 Worst Band Breakups of All Time

The 10 Most Important South American Leaders

The 7 Most Successful Casting Show Winners

The 10 Most Peaceful Countries in the World

5 Big Reasons Communism Failed

The 15 Most Famous Carl Icahn Quotes

10 Scary Animals that are Actually Harmless

The 8 Most Famous Singer-Actors in Entertainment

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!